Institute for Research, Development and Innovation (IRDI), International Medical University, 5700, Kuala Lumpur, Malaysia.
Faculty of Tropical Heath and Medicine, James Cook University, Queensland, Australia.
Malar J. 2021 Jul 3;20(1):302. doi: 10.1186/s12936-021-03836-6.
Malaria is still a major public health problem in sub-Saharan Africa and South-east Asia. The clinical presentations of malaria infection vary from a mild febrile illness to life-threatening severe malaria. Toll like receptors (TLRs) are postulated to be involved in the innate immune responses to malaria. Individual studies showed inconclusive findings. This study aimed to assess the role of TLR4 (D299G, T399I) and TLR9 (T1237C, T1486C) in severity or susceptibility of malaria by meta-analysis of data from eligible studies.
Relevant case-control studies that assessed the association between TLR 4/9 and malaria either in susceptibility or progression were searched in health-related electronic databases. Quality of included studies was evaluated with Newcastle-Ottawa scale. Pooled analyses for specific genetic polymorphisms were done under five genetic models. Stratified analysis was done by age and geographical region (Asian countries vs non-Asian countries).
Eleven studies (2716 cases and 2376 controls) from nine endemic countries were identified. Five studies (45.4%) obtained high score in quality assessment. Overall, a significant association between TLR9 (T1486C) and severity of malaria is observed in allele model (OR: 1.26, 95% CI: 1.08-1.48, I = 0%) or homozygous model (OR: 1.55, 95% CI: 1.08-2.28, I = 0%). For TLR9 (T1237C), a significant association with severity of malaria is observed in in heterozygous model (OR:1.89, 95% CI: 1.11-3.22, I = 75%). On stratifications, TLR9 (T1486C) is only significantly associated with a subgroup of children of non-Asian countries under allele model (OR: 1.25, 95% CI: 1.02-1.38), while 1237 is with a subgroup of adults from Asian countries under heterozygous model (OR: 2.0, 95% CI: 1.09-3.64, I = 39%). Regarding the susceptibility to malaria, TLR9 (T1237C) is significantly associated only with the children group under recessive model (OR: 2.21, 95% CI: 1.06-4.57, I85%) and homozygous model (OR: 1.49, 95% CI: 1.09-2.0, I = 0%). For TLR4 (D299G, T399I), none is significantly associated with either severity of malaria or susceptibility to malaria under any genetic models.
The findings suggest that TLR 9 (T1486C and T1237C) seems to influence the progression of malaria, under certain genetic models and in specific age group of people from specific geographical region. TLR 9 (T1237C) also plays a role in susceptibility to malaria under certain genetic models and only with children of non-Asian countries. To substantiate these, future well designed studies with larger samples across endemic countries are needed.
疟疾仍然是撒哈拉以南非洲和东南亚的一个主要公共卫生问题。疟疾感染的临床表现从轻微发热疾病到危及生命的严重疟疾不等。Toll 样受体 (TLR) 被认为参与了疟疾的固有免疫反应。个别研究结果不一致。本研究旨在通过对合格研究的数据进行荟萃分析,评估 TLR4 (D299G、T399I) 和 TLR9 (T1237C、T1486C) 在疟疾严重程度或易感性中的作用。
在健康相关电子数据库中搜索了评估 TLR 4/9 与疟疾易感性或进展之间关系的病例对照研究。使用纽卡斯尔-渥太华量表评估纳入研究的质量。在五个遗传模型下对特定遗传多态性进行了汇总分析。按年龄和地理区域(亚洲国家与非亚洲国家)进行分层分析。
从九个流行国家确定了 11 项(2716 例病例和 2376 例对照)研究。五项研究(45.4%)在质量评估中获得高分。总体而言,TLR9 (T1486C) 等位基因模型(OR:1.26,95%CI:1.08-1.48,I=0%)或纯合模型(OR:1.55,95%CI:1.08-2.28,I=0%)与疟疾严重程度显著相关。对于 TLR9 (T1237C),在杂合模型(OR:1.89,95%CI:1.11-3.22,I=75%)中观察到与疟疾严重程度的显著关联。在分层分析中,TLR9 (T1486C) 仅在非亚洲国家儿童的亚组中,在等位基因模型下与疟疾严重程度显著相关(OR:1.25,95%CI:1.02-1.38),而 1237 则在亚洲国家的成人亚组中在杂合模型下与疟疾严重程度显著相关(OR:2.0,95%CI:1.09-3.64,I=39%)。关于对疟疾的易感性,TLR9 (T1237C) 仅在隐性模型(OR:2.21,95%CI:1.06-4.57,I85%)和纯合模型(OR:1.49,95%CI:1.09-2.0,I=0%)下与亚组儿童显著相关。对于 TLR4 (D299G、T399I),在任何遗传模型下,均与疟疾的严重程度或易感性均无显著关联。
研究结果表明,TLR 9 (T1486C 和 T1237C) 似乎在特定遗传模型和特定地理区域特定年龄组的人群中影响疟疾的进展。TLR 9 (T1237C) 在特定遗传模型下也在易感性中起作用,并且仅在非亚洲国家的儿童中起作用。为了证实这一点,需要在流行国家进行更大样本量的精心设计的研究。